These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3158689)

  • 41. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
    Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
    Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
    Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
    Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J
    Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
    Goto T; Nunoki K; Satoh K; Taira N
    Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term enoximone therapy in unstable chronic heart failure.
    Treese N; Rhein S; Erbel R; Meyer J
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S78-83. PubMed ID: 2480491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enoximone. A review of its pharmacological properties and therapeutic potential.
    Vernon MW; Heel RC; Brogden RN
    Drugs; 1991 Dec; 42(6):997-1017. PubMed ID: 1724645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of long-term therapy with oral piroximone on resting hemodynamics, peak aerobic capacity, and the anaerobic threshold in patients with heart failure.
    Nemanich JW; Shurman AJ; Rossen JD; Kremser C; Davis F; Rajfer SI
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):580-8. PubMed ID: 2447409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
    Kereiakes DJ; Viquerat C; Lanzer P; Botvinick EH; Spangenberg R; Buckingham M; Parmley WW; Chatterjee K
    Am Heart J; 1984 Nov; 108(5):1278-84. PubMed ID: 6238512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term therapy of chronic cardiac insufficiency using enoximone].
    Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
    Berti S; Palmieri C; Ravani M; Bonini R; Iascone MR; Clerico A; Manfredi C; Iervasi G; Ferrazzi P; Biagini A
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):81-7. PubMed ID: 8723174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dose-response study of intravenous enoximone in congestive heart failure.
    Erbel R; Meyer J; Diefenbach C; Delorme G; Bourdarias JP; Vernant P; Lellouche D; Mattioli G; Barbieri A; Installe E
    Am J Cardiol; 1987 Aug; 60(5):31C-36C. PubMed ID: 2956865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term oral enoximone therapy in chronic cardiac failure.
    Maskin CS; Weber KT; Janicki JS
    Am J Cardiol; 1987 Aug; 60(5):63C-67C. PubMed ID: 2956871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent.
    Renard M; Walter M; Liebens I; Dresse A; Bernard R
    Chest; 1988 Jun; 93(6):1159-64. PubMed ID: 3371093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic effects of prolonged intravenous therapy with enoximone in patients with severe congestive heart failure.
    Ferry DR; Kennedy GT; O'Rourke RA; Crawford MH
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):115-22. PubMed ID: 2450249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.